United Therapeutics Corp (UTHR)
276.02
+1.35
(+0.49%)
USD |
NASDAQ |
May 21, 15:51
United Therapeutics Debt to Equity Ratio: 0.1124 for March 31, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
March 31, 2024 | 0.1124 |
December 31, 2023 | 0.117 |
September 30, 2023 | 0.1401 |
June 30, 2023 | 0.1478 |
March 31, 2023 | 0.1562 |
December 31, 2022 | 0.1668 |
September 30, 2022 | 0.1754 |
June 30, 2022 | 0.1853 |
March 31, 2022 | 0.1916 |
December 31, 2021 | 0.2021 |
September 30, 2021 | 0.2089 |
June 30, 2021 | 0.2198 |
March 31, 2021 | 0.2322 |
December 31, 2020 | 0.2356 |
September 30, 2020 | 0.2437 |
June 30, 2020 | 0.2586 |
March 31, 2020 | 0.2713 |
December 31, 2019 | 0.3057 |
September 30, 2019 | 0.3682 |
June 30, 2019 | 0.4091 |
March 31, 2019 | 0.4491 |
December 31, 2018 | 0.089 |
September 30, 2018 | 0.0922 |
June 30, 2018 | 0.0967 |
March 31, 2018 | 0.1047 |
Date | Value |
---|---|
December 31, 2017 | 0.1179 |
September 30, 2017 | 0.1197 |
June 30, 2017 | 0.1393 |
March 31, 2017 | 0.00 |
December 31, 2016 | 0.00 |
September 30, 2016 | 0.00 |
June 30, 2016 | 0.0005 |
March 31, 2016 | 0.0031 |
December 31, 2015 | 0.00 |
September 30, 2015 | 0.0203 |
June 30, 2015 | 0.0306 |
March 31, 2015 | 0.1036 |
December 31, 2014 | 0.0999 |
September 30, 2014 | 0.2395 |
June 30, 2014 | 0.2995 |
March 31, 2014 | 0.2129 |
December 31, 2013 | 0.2166 |
September 30, 2013 | 0.2165 |
June 30, 2013 | 0.2306 |
March 31, 2013 | 0.2391 |
December 31, 2012 | 0.2524 |
September 30, 2012 | 0.2577 |
June 30, 2012 | 0.2682 |
March 31, 2012 | 0.2617 |
December 31, 2011 | 0.2769 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.1124
Minimum
Mar 2024
0.4091
Maximum
Jun 2019
0.2174
Average
0.2055
Median
Debt to Equity Ratio Benchmarks
Liquidia Corp | 0.00 |
Ligand Pharmaceuticals Inc | 0.00 |
Esperion Therapeutics Inc | -0.8904 |
Vertex Pharmaceuticals Inc | 0.00 |
ANI Pharmaceuticals Inc | 0.5987 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 6.495B |
Total Liabilities (Quarterly) | 1.157B |
Shareholders Equity (Quarterly) | 5.338B |
Current Ratio | 3.775 |
Net Debt Paydown Yield | 0.39% |